MGAT4A/Galectin9‐Driven N‐Glycosylation Aberration as a Promoting Mechanism for Poor Prognosis of Endometrial Cancer with TP53 Mutation
Abstract Emerging evidence recognizes aberrant glycosylation as the malignant characteristics of cancer cells, but little is known about glycogenes’ roles in endometrial carcinoma (EC), especially the most aggressive subtype carrying TP53 mutations. Using unsupervised hierarchical clustering, an 11‐...
Saved in:
| Main Authors: | Zhen Zhu, Jingya Sun, Weiqing Xu, Qinghe Zeng, Hanyi Feng, Lijuan Zang, Yinyan He, Xiao He, Na Sheng, Xuelian Ren, Guobin Liu, He Huang, Ruimin Huang, Jun Yan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202409764 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MGAT4EP promotes tumor progression and serves as a prognostic marker for breast cancer
by: Lin Zhong, et al.
Published: (2025-12-01) -
Proximity Labeling-Based Identification of MGAT3 Substrates and Revelation of the Tumor-Suppressive Role of Bisecting GlcNAc in Breast Cancer via GLA Degradation
by: Bowen Wang, et al.
Published: (2025-01-01) -
Are viral vector-mediated therapies compatible with aberrant glycosylation?
by: I.J.J. Muffels, et al.
Published: (2025-09-01) -
Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer
by: Regina Mirgayazova, et al.
Published: (2024-12-01) -
In-frame germline TP53 variant impairs p53 oligomerization and predisposes to cancer
by: Lucie Vanikova, et al.
Published: (2025-08-01)